Aptorum Group Limited (APM)
NASDAQ: APM · Real-Time Price · USD
0.805
+0.005 (0.63%)
At close: Mar 6, 2026, 4:00 PM EST
0.800
-0.005 (-0.63%)
After-hours: Mar 6, 2026, 4:10 PM EST
Aptorum Group Employees
Aptorum Group had 1 employees as of December 31, 2024. The number of employees decreased by 2 or -66.67% compared to the previous year.
Employees
1
Change (1Y)
-2
Growth (1Y)
-66.67%
Revenue / Employee
n/a
Profits / Employee
-$1,975,675
Market Cap
6.51M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Aptevo Therapeutics | 37 |
| Theriva Biologics | 22 |
| Processa Pharmaceuticals | 10 |
| XTL Biopharmaceuticals | 10 |
| Aprea Therapeutics | 8 |
| Immuron | 7 |
| Mustang Bio | 6 |
| Can-Fite BioPharma | 5 |
APM News
- 4 weeks ago - Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB's Automated APOE Testing Platform for Alzheimer's Disease - GlobeNewsWire
- 3 months ago - DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer's Disease (CTAD) 2025 Conference - GlobeNewsWire
- 4 months ago - Andean Precious Metals Corp. (APM:CA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Aptorum Group Limited Announces Up To $6 Million Registered Direct Offering - GlobeNewsWire
- 5 months ago - As part of the planned merger with DiamiR Biosciences, Aptorum Group will expand its board and management team with seasoned executives - GlobeNewsWire
- 6 months ago - Aptorum Group and DiamiR Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 7 months ago - Why Is Nano-Cap Aptorum Stock Rallying On Thursday? - Benzinga
- 7 months ago - DiamiR Biosciences and Aptorum Group Announce New York State Approval for DiamiR's APOE Genotyping Test - GlobeNewsWire